Rare disease research: Breaking the privacy barrier.
Due to the few patients affected, rare disease research has to count on international registries to exist in order to produce significant research outputs. Data sharing of registries is therefore a unique resource to allow rare disease research to flourish and any lost data will jeopardize the quality of an already extremely difficult research. The rules usually applied to research such as the right to withdraw or the need for specific consent for every use of data can be detrimental in order to get effective results. Privacy rights regulated through traditional informed consent mechanisms have been regarded as a major barrier in order to effectively share data worldwide. Some authors argue that this barrier hampers results that could be beneficial to the patients so that another right will be overstated: the right to quality healthcare. We argue in this paper that privacy has been often interpreted just one-sided as the right to secrecy but it can entail another meaning: the right to manage one's own private sphere. Managing it pertains, not only to the right to deny access, but also to the right to grant access. At the same time research on patient participation and transparency shows that new forms of IT-based informed consent can provide a good balance between the right of individuals to be in control of their data and the opportunity for science to pursue international research.
Centre for Research Ethics & Bioethics (CRB), Uppsala University, Box 564, SE-751 22 Uppsala, Sweden.
Deborah
D
Mascalzoni
Direttore Scientifico Istituto Oncologico-Bari, Italy; Direttore Laboratorio Oncologia Sperimentale Clinica Istituto Oncologico-Bari, Italy.
Angelo
A
Paradiso
Centre for Research Ethics & Bioethics (CRB), Uppsala University, Box 564, SE-751 22 Uppsala, Sweden.
Matts
M
Hansson
Informed consent; Privacy; Private sphere; Research barriers